International Journal of Endocrinology
Volume 2017 (2017), Article ID 4827469, 1 page
https://doi.org/10.1155/2017/4827469

Corrigendum

Corrigendum to “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort”

Nicole Yurgin,¹ Sally Wade,² Sacha Satram-Hoang,³ David Macarios,¹ and Marc Hochberg⁴

¹Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA
²Wade Outcomes Research and Consulting, 358 South 700 East, Suite B432, Salt Lake City, UT 84102, USA
³Q.D. Research, Inc., 8789 Auburn Folsom Road, Suite C501, Granite Bay, CA 95746, USA
⁴Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, 10 S. Pine Street, MSTF 8-34, Baltimore, MD 21201, USA

Correspondence should be addressed to Nicole Yurgin; nyurgin@amgen.com

Received 18 June 2017; Accepted 26 July 2017; Published 25 October 2017

Copyright © 2017 Nicole Yurgin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” [1], there was an error regarding the FRAX® tool, which should be clarified as follows:

The article notes “The WHO fracture risk assessment tool (FRAX) is a computer-based algorithm that assesses fracture probability of men and women [1].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.

References

N. Yurgin, S. Wade, S. Satram-Hoang, D. Macarios, and M. Hochberg, “Prevalence of fracture risk factors in postmenopausal women enrolled in the POSSIBLE US treatment cohort,” International Journal of Endocrinology, vol. 2013, Article ID 715025, 9 pages, 2013.

N. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, no. 12, p. 862, 2016.